IXICO has developed an artificial intelligence tool designed to assist radiologists in identifying cerebral microbleeds on MRI scans. This tool is intended for use in Alzheimer's disease research. The company presented its findings at the 2026 Clinical Trials on Alzheimer’s Disease conference. AI
IMPACT This tool could improve the efficiency and accuracy of diagnosing cerebral microbleeds, aiding Alzheimer's disease research.
RANK_REASON The item describes a specific AI tool developed by a company for a particular medical application.
Read on Mastodon — mastodon.social →
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →